Alterations in thyroid hormone status have been associated with a number of metabolic abnormalities including alterations in resting metabolic rate, exercise capacity and cardiac function. This study is a prospective protocol designed to examine changes in energy expenditure in patients with overt and subclinical hyperthyroidism and hypothyroidism compared to healthy controls. Patients with subclinical disease have been thought to have a milder form of thyroid dysfunction compared to patients with overt thyroid disease.
One aim of this study is to determine whether alterations in metabolism occur in patients with mild or subclinical thyroid disease compared to normal controls and patients with severe thyroid function abnormalities. Additionally, this study aims to determine whether normalization of thyroid function results in return of metabolic parameters to values observed in control patients. Patients are recruited from Endocrinology and General Internal Medicine clinics at the University of Colorado Health Sciences Center. At the current time, data has only been analyzed for the subgroup of patients with either subclinical or overt hyperthyroidism in comparison to normal controls. All patients were admitted overnight for whole body indirect calorimetry to measure 24 hour energy expenditure and exercise capacity testing. On average, all patients were in energy balance during the calorimetry stay and no significant group differences were observed in this measure. Fat free mass measured by DEXA did not differ between groups. Hyperthyroid patients demonstrated significantly higher 24 hour energy expenditures than both subclinical hyperthyroid patients and controls. There was a significant positive correlation between free thyroid hormone serum levels (Free T4) and 24 hour energy expenditure. Hyperthyroid patients expended an average of 759 kcal/d and subclinical hyperthyroid patients expended 243.9 kcal/d more than controls. The 24EE, when adjusted for fat free mass, was significantly higher in hyperthyroid patients compared to subclinical hyperthyroid patients and controls. Exercise capacity was also assessed in all patients. Subclinical hyperthyroid and overt hyperthyroid patients demonstrated reduced exercise capacity compared to controls. A subset of subclinical hyperthyroid patients (n=9) were retested after normalization of their thyroid function. Measurements of body mass index, fat free mass, and 24 hour energy expenditure improved, but due to the small number of patients did not reach statistical significance. In conclusion, subclinical and overt hyperthyroidism induced elevations in 24 hour and sleeping energy expenditure. Subclinical hyperthyroidism patients have reduced exercise capacity compared to controls. These data suggest a continuum of metabolic derangements in patients with excess thyroid hormone and patients with mild or subclinical hyperthyroidism have measurable changes in energy expenditure and exercise capacity.

Project Start
1999-12-01
Project End
2000-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
39
Fiscal Year
2000
Total Cost
$32,212
Indirect Cost
Name
University of Colorado Denver
Department
Type
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Millstein, Richard J; Pyle, Laura L; Bergman, Bryan C et al. (2018) Sex-specific differences in insulin resistance in type 1 diabetes: The CACTI cohort. J Diabetes Complications 32:418-423
Martin, Maureen P; Naranbhai, Vivek; Shea, Patrick R et al. (2018) Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1. J Clin Invest 128:1903-1912
Nowak, Kristen L; You, Zhiying; Gitomer, Berenice et al. (2018) Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol 29:571-578
Haas, David W; Bradford, Yuki; Verma, Anurag et al. (2018) Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events. Pharmacogenet Genomics 28:179-187
Venuto, Charles S; Lim, Jihoon; Messing, Susan et al. (2018) Inflammation investigated as a source of pharmacokinetic variability of atazanavir in AIDS Clinical Trials Group protocol A5224s. Antivir Ther 23:345-351
Li, Binglan; Verma, Shefali S; Veturi, Yogasudha C et al. (2018) Evaluation of PrediXcan for prioritizing GWAS associations and predicting gene expression. Pac Symp Biocomput 23:448-459
Hayden, Kathleen M; Baker, Laura D; Bray, George et al. (2018) Long-term impact of intensive lifestyle intervention on cognitive function assessed with the National Institutes of Health Toolbox: The Look AHEAD study. Alzheimers Dement (Amst) 10:41-48
Shah, V N; Sippl, R; Joshee, P et al. (2018) Trabecular bone quality is lower in adults with type 1 diabetes and is negatively associated with insulin resistance. Osteoporos Int 29:733-739
Jensen, Thomas; Bjornstad, Petter; Johnson, Richard J et al. (2018) Copeptin and Estimated Insulin Sensitivity in Adults With and Without Type 1 Diabetes: The CACTI Study. Can J Diabetes :
Dad, Taimur; Abebe, Kaleab Z; Bae, K Ty et al. (2018) Longitudinal Assessment of Left Ventricular Mass in Autosomal Dominant Polycystic Kidney Disease. Kidney Int Rep 3:619-624

Showing the most recent 10 out of 1065 publications